Summary
The severity of asthma varies within and between individuals, and the disease has a variable impact on quality of life. Disease severity can be modified but not cured by long term anti-inflammatory therapy. Compliance with, or adherence to, such therapeutic regimens is difficult, and it is affected by a number of factors. Patterns of compliance are variable; some patients take only half the prescribed drug all the time, while others take all their prescribed medication for a while and then ‘take a break’. Understandably, there is no single factor that would account for such a variety of human behaviour, but generally the frequency and ease of drug administration, as well as adverse effects (real or imagined), can affect compliance. Poor communication regarding the precise regimen will also impair compliance.
Psychosocial factors such as depression, poor interpersonal skills and coping strategies, and rejection of the diagnosis will lead to lower levels of compliance. Interventional programmes using a combination of education, skills training and methods to modify behaviour are needed to improve the quality of life in asthmatics. The role of the newer generations of once-/twice-daily oral anti-inflammatory preparations in improving compliance requires further investigation.
Similar content being viewed by others
References
Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Clin Immunol 1989; 83: 1013–25
Guidelines on the Management of Asthma. British Thoracic Society, British Paediatric Association, Royal College of General Practitioners. Thorax 1993; 48 Suppl.: S1–24
Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, Oct 1992. Am Rev Respir Dis 1993; 148 Suppl. 4: S1–26
Toogood JH, Baskervillle J, Jennings B. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid budesonide. J Allergy Clin Immunol 1982; 70: 288–9
Horn CR, Clark TJH, Cochrane GM. Can the morbidity of asthma be reduced by high dose inhaled therapy? A prospective study. Respir Med 1990; 84: 61–6
Jones PW. Quality of life, health economics and asthma. Eur Respir Rev 1995; 5 (Rev. 30): 279–83
Juniper EF, Guyatt GM, Ferrie PJ, et al. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832–8
Horn CR, Clark TJH, Cochrane GM. Compliance with inhaled therapy and morbidity from asthma. Respir Med 1990; 84: 67–70
Sackett DL. The magnitude of compliance with non-compliance. In: Sackett DL, Taylor DW, Haynes RB, editors. Compliance with therapeutic regimens. Baltimore: Johns Hopkins University Press, 1979: 323–5
Cochrane GM. Compliance in asthma. Eur Respir Rev 1995; 5(26): 116–9
Spector SL. Is your asthmatic really complying? Ann Allergy 1985; 55: 552–6
Rand CS, Wise RA, Nides M, et al. Metered dose inhaler adherence in clinical trials. Am Rev Respir Dis 1992; 146: 1559–64
Cochrane GM, Bosley C. Compliance with inhaled therapy in asthma. Eur Respir Rev 1994; 18: 92–4
Chowienczyk PJ, Lawson CP, Harris J, et al. Electronic diary card to record physiological measurements. Lancet 1992; 339: 251
Hyland ME, Kenyon CAP, Allen R, et al. Diary keeping in asthma — comparison of the written and electronic methods. BMJ 1993; 306: 487–9
Levine RJ. Monitoring for adherence — ethical considerations [editorial]. Am J Crit Care Med 1994; 149: 287–8
Yeung M, O’Connor SA, Cochrane GM. Compliance with prescribed drug therapy and the management of asthma. Respir Med 1994; 88: 31–5
Kossoy AF, Hill M, Lin FL, et al. Are theophylline ‘levels’ a reliable indicator of compliance? J Allergy Clin Immunol 1989; 84: 60–5
Hendeles L, Massanari M, Weinberg M. Theophylline. In: Middleton EJ, Reed CE, Ellis EF et al., editors. Allergy principles and practice. 3rd ed. St Louis: The CV Mosley Co, 1988: 673–714
Eney RD, Goldstein EO. Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels. Paediatrics 1976; 57: 513–7
Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment approach. JAMA 1989; 261: 3273–7
Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance [see comments]. Arch Intern Med 1990; 150: 1881–4. Comment in: Arch Intern Med 1991; 151 (6): 1236–7
Spector SL, Kinzman R, Mawhinney H, et al. Compliance of patients with an experimental aerosolised medication: implications for controlled trials. J Allerg Clin Immunol 1986; 77: 65–70
Mann M, Eliasson A, Patel K, et al. A comparison of the effects of b.i.d. and q.i.d. dosing on compliance with inhaled flunizolide. Chest 1992; 101: 496–9
Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992; 146: 1559–64
Dompeling E, Von Grunsven PM, VanSchayck CP, et al. Treatment with inhaled steroids in asthma and chronic bronchitis. Long term compliance and inhaler technique. Fam Pract 1992; 9(2): 161–6
Bosley CM, Parry DT, Cochrane GM. Patient compliance with inhaled medication. Does combining beta agonist with corticosteroids improve compliance? Eur Respir J 1994; 7: 504–9
Crompton GK. The adult patients’ difficulties with inhalers. Lung 1990; 168 Suppl.: 658–62
Worth H. Patient education in asthmatic adults. Lung 1990; 168 Suppl.: 463–8
Brewis RAL. Patient education, self management plans and peak flow measurement. Respir Med 1991; 85: 457–62
Osman LM, Russell IT, Friend JR, et al. Predicting patients’ attitudes to asthma medication. Thorax 1993; 48: 827–30
Mayo PH, Richman J, Harris HW. Results of a programme to reduce admissions for adult asthma. Arch Intern Med 1990; 112: 864–71
Sibbald B. Patient self care in acute asthma. Thorax 1989; 44: 97–101
Osman L. The patient perspective: what should a new anti-asthma agent provide? Drugs. In press
Hayes-Baulista DE. Modifying the treatment: patient compliance, patient control and medical care. Soc Sci Med 1976; 10: 233–8
Haynes RB. Determinants of compliance: the disease and the mechanics of treatment. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in health care. Baltimore: Johns Hopkins University Press, 1979: 49–62
Blackwell B, Gutmann MC. Compliance. In: Bilpott CJ, editor. Handbook of hypertension. Vol. 6. Epidemiology of hypertension. Amsterdam: Elsevier Science Publishers BV, 1985: 453–72
Palo VA, Mayr PH, Friedman P. Demographic influences in asthma hospital admission rates in New York City. Chest 1994; 106: 447–51
Bosley C, Fosbury JA, Cochrane GM. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995; 8: 899–904
Rand CS, Nides M, Cowles MK, et al. Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med 1995; 152: 580–8
Yellowless PM, Haynes S, Potts N, et al. Psychiatric morbidity in patients with life threatening asthma: initial report of a controlled study. Med J Aust 1988; 149: 246–9
Kinsman RA, Dukes JF, Jones NF, et al. Anxiety reduction in asthma: four catches to general application. Psychosom Med 1980; 42(4): 397–405
Bosley CM, Fosbury JA, Cochrane GM. Psychological factors associated with poor patient compliance with inhaled treatment in asthma. Am J Respir Crit Care 1994; 149(4): A248
Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Arch Int Med 1994; 154: 1349–53
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MacCochrane, G. Compliance and Outcomes in Patients with Asthma. Drugs 52 (Suppl 6), 12–19 (1996). https://doi.org/10.2165/00003495-199600526-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199600526-00004